Home
Conditions
Leukemia, Myeloid, Acute

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,461 public trials 543 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Recruiting

A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies

NCT06820268

Conditions: Acute Myeloid Leukemia, B-cell Lymphoma, Bone Marrow Diseases, +16 more
Locations: Beijing Cancer Hospital Beijing, China

Sun Yat-sen University Cancer Center Guangdong, China

Affiliated Hospital of Hebei University Hebei, China

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Hubei, China

View Trial Details

Recruiting

Relation Between Venetoclax Plasma Concentration and Remission in Adults with Acute Myeloid Leukemia (PREDICLAX)

NCT06045819

Conditions: Adult Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: CHU de Caen Caen, France

View Trial Details

Recruiting

CD123-CD16-NK Cells Immunotherapy for AML

NCT06835140

Conditions: AML (Acute Myelogenous Leukemia), CD123+ Acute Myeloid Leukemia, Hematologic Diseases, +7 more
Locations: Chinese PLA General Hospital Beijing, China

View Trial Details

Recruiting

PTCy and ATG for MSD and MUD Transplants

NCT06299462

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +20 more
Locations: Instituto Nacional de Cancer Rio de Janeiro, Brazil

View Trial Details

Recruiting

Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML

NCT06737523

Conditions: Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +11 more
Locations: The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China

View Trial Details

Recruiting

Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients

NCT06651866

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China

View Trial Details

Recruiting

Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML

NCT06827899

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Bing Xu Xiamen, Fujian, China

View Trial Details

Recruiting

VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

NCT05603884

Conditions: AML Stage, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Bing Xu Xiamen, Fujian, China

View Trial Details

Recruiting

Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies

NCT05991908

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

Zhongshan Hospital, Xianmen University Xiamen, Fujian, China

923th Hospital PLA Nanning, Guangxi, China

First Affiliated Hospital of Nanjin Medical Unviersity Nanjin, Jiangsu, China

View Trial Details

Recruiting

Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia

NCT05870995

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Blood & Marrow Transplantation Center, RuiJin Hospital Shanghai, Shanghai Municipality, China

Department of Hematology, Shanghai No 6 Hospital Shanghai, China

Shanghai ZhaXin Hospital Shanghai, China

View Trial Details

Leukemia, Myeloid, Acute

Leukemia, Myeloid, Acute trial results

Related conditions